No Data
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) --
Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.Shares of Nike Inc (NYSE:NKE) fell sharply in pre-market trading after the company reported
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:Nike Inc. (NYSE:NKE) reported mixed first-quarter financial results.
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why
Mangoceuticals, Inc. (NASDAQ:MGRX) shares fell 12.24% to $0.42 in after-hours trading Thursday after the company announced its former subsidiary secured a $2.5 million strategic investment.
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche
Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company's Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock DALLAS, TEXAS, Oct. 01, 2026
Express News | Mangoceuticals Secures $2.5 Million Strategic Investment in Mangorx Ip Holdings; Receives Initial $1.75 Million Tranche